I. Introductory Chapters: Setting the Scene for the Neuroscience of
Development 1. The brain and its structures: An overview 2. Neural
tube defects: Embryonic origin, clinical features and cell survival
equilibrium impact 3. Chemical substances affecting
neurodevelopment 4. High-risk babies and Neurodevelopmental outcome
5. Genomic Imprinting and neurodevelopment 6. Insights from model
systems: Alcohol, neurodevelopment and zebrafish 7. Early life
nutrition and brain development: Maternal iodine nutrition and
neurodevelopment 8. Endocrine Aspects of Development. Thyroid
hormone actions in neurological processes during brain
development
II. Impairments and Diseases 9. Pediatric brain tumors 10.
Neurofibromatosis Type 1: From cellular phenotypes to human brain
function 11. The role and development of neural crest cells 12.
Spina Bifida: A Biopsychosocial Perspective 13. Diabetic
ketoacidosis and neurodevelopment 14. Four-dimensional features of
fetal brain: Applications to diabetes 15. Prenatally exposed to
nicotine and neurodevelopment 16. Maternal methamphetamine and
impact on the brain 17. Alcohol, cannabis and brain development 18.
The Environmental Pollutant Trichloroethylene Disrupts Key Neural
Pathways During Brain Development 19. Developmental neurotoxicity
of the herbicide atrazine 20. Neurodevelopmental delays and in
utero hyperemesis gravidarum 21. Neurodevelopment and Infantile
Epileptic Encephalopathy-9 (EIEE9) 22. Neurodevelopment in Turner
syndrome 23. Very preterm children and the impact on
neurodevelopmental outcomes 24. Linking congenital heart disease
and brain functional connectivity in newborns 25. Brain Growth in
Congenital Heart Disease from Prenatal Environment to Adulthood 26.
Linking dopamine, amphetamine and neurodevelopment 27.
Developmental coordination disorder
III. Biomarkers, Screening, Methods and Diagnosis 28.
Neurodevelopment and the The Ages and Stages Questionnaire, third
edition (ASQ-3) 29. Screening for Attention Deficit Hyperactivity
Disorder in children 30. The Mini-Mental State Pediatric
Examination screening tool: Italian perspectives 31. Predictors of
neurodevelopment in preterm infants: From the neonatal intensive
care unit into adulthood 32. The antenatal fetal neurodevelopmental
test: Uses and applications
IV: Management and Treatments 33. Pain, evaluation and management
in neurodevelopmental conditions 34. Use of levetiracetam: Features
and applications to neonatal seizures 35. Quetiapine treatment in
paediatric scenarios 36. Treatments with cannabinoids and brain
development 37. Pediatric dystonia and deep brain stimulation 38.
Use of repetitive transcranial magnetic stimulation in
neurodevelopment: A narrative review 39. Cognitive behavioral
therapy in children with anxiety disorders 40. Cognitive behavioral
therapy for anxiety in children with autism spectrum disorder 41.
Nutritional treatment in fetal alcohol spectrum disorder 42.
Nurturing the Developing Brain to Reduce Neurological Delay 43.
Normalizing perinatal neurological development via intervention
V. Models and Modelling 44. Microplatforms as a Model for
Neurological Conditions 45. Disease models in neurodevelopmental
disorders 46. Endosulfan and impact on neurodevelopment: Modelling
with zebrafish (Danio rerio) 47. Neurodevelopment of the zebrafish
spinal serotonin system 48. Inbred mouse model of brain development
and intestinal microbiota 49. The myelin mutant taiep rat as a
model of developmental disorder 50. The MAM-E17 neurodevelopmental
model of schizophrenia
VI. Resources 51. Research and recommended resources in the
neuroscience of development
Colin R. Martin RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol,
AFBPsS, C.Sci is Professor of Clinical Psychobiology and Applied
Psychoneuroimmunology and Clinical Director of the Institute of
Health and Wellbeing at the University of Suffolk, UK. He is a
Chartered Health Psychologist and a Chartered Scientist. He also
trained in analytical biochemistry, this aspect reflecting the
psychobiological focus of much of his research within mental
health. He has published or has in press well over 300 research
papers and book chapters. He is a keen book author and editor
having written and/or edited more than 50 books. These outputs
include the prophetic insight into the treatment of neurological
disease, Handbook of Behavior, Food and Nutrition (2011),
Nanomedicine and the Nervous System (2012), Oxidative Stress and
Dietary Antioxidants in Neurological Disease (2020), Zika Virus
Impact, Diagnosis, Control and Models (2021), Factors Affecting
Neurodevelopment: Genetics, Neurology, Behavior and Diet (2021),
Diagnosis and Treatment of Spinal Cord Injury (2022), The
Neurobiology, Physiology, and Psychology of Pain (2022) and The
Handbook of Lifespan Cognitive Behavioral Therapy: Childhood,
Adolescence, Pregnancy, Adulthood, and Aging (2023). Professor
Martin is particularly interested in all aspects of the
relationship between underlying physiological substrates and
behavior, particularly in how these relationships manifest in both
acute and chronic psychiatric disorder. He has published original
research germane to significant mental health disorders including
the areas of schizophrenia, anxiety, depression, self-esteem,
alcohol and drug dependency, high secure forensic mental health and
personality disorder. He has a keen interest in the impact of
postviral illness and is actively involved in clinical research
post-Covid pandemic and in particular, the impact of Long Covid on
psychological, neurological, physiological and social functioning.
He is involved in collaborative International research with many
European and Non-European countries. Victor R. Preedy BSc, PhD,
DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in
Biology and Physiology with Pharmacology. After gaining his
University of London PhD, he received his Membership of the Royal
College of Pathologists. He was later awarded his second doctorate
(DSc), for his contribution to protein metabolism in health and
disease. He is Professor of Clinical Biochemistry (Hon) at King’s
College Hospital and Emeritus Professor of Nutritional Biochemistry
at King’s College London. He has Honorary Professorships at the
University of Hull, and the University of Suffolk. Professor Preedy
was the Founding Director and then long-term Director of the
Genomics Centre at King’s College London from 2006 to 2020.
Professor Preedy has been awarded fellowships of the Royal Society
of Biology, the Royal College of Pathologists, the Royal Society
for the Promotion of Health, the Royal Institute of Public Health,
the Royal Society for Public Health, the Royal Society of Chemistry
and the Royal Society of Medicine. He carried out research when
attached to the National Heart Hospital (part of Imperial College
London), The School of Pharmacy (now part of University College
London) and the MRC Centre at Northwick Park Hospital. He has
collaborated with international research groups in Finland, Japan,
Australia, USA, and Germany. To his credit, Professor Preedy has
published over 750 articles, which includes peer-reviewed
manuscripts based on original research, abstracts and symposium
presentations, reviews and edited books. Dr Rajkumar Rajendram is a
clinician scientist with a focus on internal medicine, anaesthesia,
intensive care and peri-operative medicine. He graduated with
distinctions from Guy’s, King’s and St. Thomas Medical School,
King’s College London in 2001. As an undergraduate he was awarded
several prizes, merits and distinctions in pre-clinical and
clinical subjects.
Dr Rajendram began his post-graduate medical training in general
medicine and intensive care in Oxford. He attained membership of
the Royal College of Physicians (MRCP) in 2004 and completed
specialist training in acute and general medicine in Oxford in
2010. Dr Rajendram subsequently practiced as a Consultant in Acute
General Medicine at the John Radcliffe Hospital, Oxford.
Dr Rajendram also trained in anaesthesia and intensive care in
London and was awarded a fellowship of the Royal College of
Anaesthetists (FRCA) in 2009. He completed advanced training in
regional anaesthesia and intensive care. He was awarded a
fellowship of the Faculty of Intensive Care Medicine (FFICM) in
2013 and obtained the European diploma of intensive care medicine
(EDIC) in 2014. He then moved to the Royal Free London Hospitals as
a Consultant in Intensive Care, Anaesthesia and Peri-operative
Medicine. He has been a fellow of the Royal College of Physicians
of Edinburgh (FRCP Edin) and the Royal College of Physicians of
London (FRCP Lond) since 2017 and 2019 respectively. He is
currently a Consultant in Internal Medicine at King Abdulaziz
Medical City, National Guard Heath Affairs, Riyadh, Saudi
Arabia.
Dr Rajendram’s focus on improving outcomes from Coronavirus Disease
2019 (COVID-19) has involved research on point of care ultrasound
and phenotypes of COVID-19. Dr Rajendram also recognises that
nutritional support is a fundamental aspect of medical care. This
is particularly important for patients with COVID-19. As a
clinician scientist he has therefore devoted significant time and
effort into nutritional science research and education. He is an
affiliated member of the Nutritional Sciences Research Division of
King’s College London and has published over 400 textbook chapters,
review articles, peer-reviewed papers and abstracts.
Ask a Question About this Product More... |